Second RNAi drug approved

被引：20

作者：

不详

机构：

来源：

关键词：

D O I：

10.1038/s41587-020-0494-3

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：385 / 385

页数：1

共 50 条

[1] Second RNAi drug approved
Nature Biotechnology, 2020, 38 : 385 - 385
[2] First RNAi drug approved
Cross, Ryan
CHEMICAL & ENGINEERING NEWS, 2018, 96 (33) : 5 - 5
[3] Second Topical Drug Approved for Molluscum Contagiosum
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2024, 124 (05) : 20 - 21
[4] The second generation RNAi drug agent which deals with RNAi escape HIV-1 variants
Habu, Y
Barnor, J
Yamamoto, N
Hashimoto, K
Miyano-Kurosaki, N
Ishikawa, K
Yamamoto, N
Ofori-Adjei, D
Takaku, H
ANTIVIRAL RESEARCH, 2006, 70 (01) : A47 - A48
[5] The Second Coming of RNAi
Bender, Eric
SCIENTIST, 2014, 28 (09): : 52 - 57
[6] Second Biosimilar Approved
Voelker, Rebecca
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (19): : 2057 - 2057
[7] RNAi in drug development
Samarsky, D
FASEB JOURNAL, 2004, 18 (08): : C148 - C148
[8] Second RNAi pathway emerges
Lucentini J.
Genome Biology, 5 (1)
[9] Second Cancer Biosimilar Approved
Voelker, Rebecca
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (03): : 220 - 220
[10] Zelnorm - Tegaserod maleate - Novartis - Second IBS drug approved, this time for constipation predominant illness
不详
FORMULARY, 2002, 37 (09) : 437 - 437